| ANOVA | Analysis of variance |
| ATP | Adenosine triphosphate |
| BC | Bladder cancer |
| cf | Cell-free |
| EMT | Epithelial-to-mesenchymal transition |
| EV | Extracellular vesicle |
| FDR | False discovery rate |
| HC | Healthy control |
| HCD | Higher-energy collisional dissociation |
| LC-MS/MS | Liquid chromatography followed by tandem mass spectrometry |
| MCL | Markov clustering |
| MIBC | Muscle-invasive bladder cancer |
| MTBE | Methyl-tert-butyl-ether |
| MVBs | multivesicular bodies |
| NMIBC | Non-muscle-invasive bladder cancer |
| NTA | Nanoparticle tracking analysis |
| PD | Proteome discoverer |
| ppm | Parts per million |
| QC | Quality control |
| SEC | Size-exclusion chromatography |
| sEV | Small extracellular vesicles |
| STRING | Search tool for the retrieval of interacting genes |
| TEM | Transmission electron microscopy |
| UF | Ultrafiltration |
| UPS | Ubiquitin proteasome system |